BioWorld - Thursday, April 30, 2026

Amanda Lanier

Articles

ARTICLES

Deal handshake and arrows sketch on chalkboard
Biopharma deals June 2023

M&A value soars with four $1B+ transactions; other deals plunge

July 17, 2023
By Amanda Lanier
The biopharma industry experienced a notable decline in deal values and activity in June 2023, with a 48.51% decrease in deal values and a 43.62% decrease in the number of deals completed compared to the previous June. M&As, however, showed a remarkable 824.59% increase in value year over year in June, thanks to several billion-dollar transactions.
Read More
Hand holding gear, dollar sign
Biopharma financings June 2023

Biopharmas raise $6.82B in June, reflecting industry resilience

July 11, 2023
By Amanda Lanier
In June 2023, biopharmas collectively raised $6.82 billion through 109 financing transactions. The amount raised is 32.95% more than last June’s $5.13 billion, and the number of transactions is up 26.74%, compared to 86 in June 2022. This echoes the 23.34% increase seen in financings in the first half of 2023 compared to last year.
Read More
Med-tech financings June 2023

$1.7B raised by med-tech in June as financing contraction continues

July 7, 2023
By Amanda Lanier
Med-tech companies raised a total of $1.7 billion in financings in June, a decrease of 21.64% compared to the same month last year. Volume of med-tech financings are also down: 30 in June 2023 compared to 41 in June 2022. Numbers are down significantly from the 56 financings worth $4.45 billion in June 2021, 76 financings worth $5.27 billion in June 2020, and 47 worth $2.08 billion in June 2019.
Read More
Hand holding gear, dollar sign
Biopharma financings June 2023

Biopharmas raise $6.82B in June, reflecting industry resilience

July 7, 2023
By Amanda Lanier
In June 2023, biopharmas collectively raised $6.82 billion through 109 financing transactions. The amount raised is 32.95% more than last June’s $5.13 billion, and the number of transactions is up 26.74%, compared to 86 in June 2022. This echoes the 23.34% increase seen in financings in the first half of 2023 compared to last year.
Read More
Nonprofit stamp
Biopharma nonprofit deals and grants May 2023

Nonprofit deal value plummets while biopharma grant value holds steady

July 3, 2023
By Amanda Lanier
Both the value and number of reported biopharma nonprofit deals has fallen significantly, being at the lowest amount in the past five years. Compared to the first five months of last year, the value of biopharma nonprofit deals has decreased by about 63%. Meanwhile, money raised via grants has fallen slightly, 6.11%, but is vastly less than the value and number seen in 2020.
Read More
Health professional pointing stethoscope at Clinical Trial words, icons

2023 clinical data compare similarly to last year

June 26, 2023
By Amanda Lanier
Clinical data in the first five months of 2023 is remarkably consistent to last year. BioWorld reported on 1,449 drugs in phase I-III this year, compared to 1,452 in the same time period in 2022. Numbers are down 12.13% from 1,649 in 2021, but up from 2020’s 1,419 and 2019’s 1,173.
Read More
Approval-stamp-blue.png
Biopharma regulatory actions and approvals May 2023

Two RSV vaccines among 19 US FDA approvals in May

June 16, 2023
By Amanda Lanier
The first five months of the year showed a slight increase in U.S. FDA approvals, though numbers are down compared to the previous four years. Worldwide approvals are down 16.67% through May, but up 5.42% compared to the previous seven years’ average.
Read More